You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BLU-263

Showing 1 - 25 of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)

Not yet recruiting
  • Advanced Systemic Mastocytosis
  • (no location specified)
Nov 2, 2022

Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)

Recruiting
  • Indolent Systemic Mastocytosis
  • Monoclonal Mast Cell Activation Syndrome
  • BLU-263
  • Placebo
  • Palo Alto, California
  • +33 more
Jul 27, 2022

Gastrointestinal Stromal Tumors (GIST), Other Relapsed or Refractory Solid Tumors Trial in Worldwide (Avapritinib)

Completed
Has Results
  • Gastrointestinal Stromal Tumors (GIST)
  • Other Relapsed or Refractory Solid Tumors
  • Scottsdale, Arizona
  • +18 more
May 20, 2022

Advanced Melanoma Trial in Belarus, Russian Federation (BCD-263, Opdivo)

Recruiting
  • Advanced Melanoma
  • Minsk, Belarus
  • +29 more
Nov 2, 2023

Refractory Chronic Cough Trial in United States (BLU-5937, Placebo)

Recruiting
  • Refractory Chronic Cough
  • Gulf Shores, Alabama
  • +30 more
Jan 23, 2023

Chronic Lymphocytic Leukemia Trial in Worldwide (ABT-263)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +9 more
Jul 8, 2022

Healthy Trial in Québec (Camlipixant + Gemfibrozil, Dabigatran etexilate + camlipixant)

Not yet recruiting
  • Healthy
  • Camlipixant + Gemfibrozil
  • Dabigatran etexilate + camlipixant
  • Québec, Quebec, Canada
    Syneos Health
Jul 17, 2023

Refractory Chronic Cough Trial in United States (BLU-5937, Placebo)

Recruiting
  • Refractory Chronic Cough
  • Scottsdale, Arizona
  • +6 more
Oct 31, 2022

Healthy Trial in Québec (Camlipixant + Rifampin, Camlipixant + Rabeprazole)

Not yet recruiting
  • Healthy
  • Camlipixant + Rifampin
  • Camlipixant + Rabeprazole
  • Québec, Quebec, Canada
    Syneos Health
Jun 2, 2023

Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

Recruiting
  • Lung Neoplasm Malignant
  • +18 more
  • Fairfax, Virginia
    New Experimental Therapeutics of Virginia (NEXT Oncology)
Mar 29, 2022

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

GIST Trial in Worldwide (avapritinib, regorafenib)

Completed
Has Results
  • GIST
  • Phoenix, Arizona
  • +113 more
Sep 9, 2022

Healthy Trial in Nottingham (BLU-5937 IR, BLU-5937 ER)

Recruiting
  • Healthy
  • BLU-5937 IR
  • BLU-5937 ER
  • Nottingham, England, United Kingdom
    Quotient Sciences
Oct 4, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial

Completed
  • Aggressive Systemic Mastocytosis
  • +3 more
  • Stanford, California
  • +10 more
Jan 12, 2023

ER+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer Trial in United States (BLU-222, Carboplatin, Ribociclib)

Recruiting
  • ER+ Breast Cancer
  • +8 more
  • Sarasota, Florida
  • +3 more
Jun 8, 2022

Healthy Volunteers Trial in Burbank (Combustible Cigarette, blu Disposable A, blu Disposable B)

Active, not recruiting
  • Healthy Volunteers
  • Combustible Cigarette
  • +5 more
  • Burbank, California
    LA Clinical Trials, LLC
Jul 11, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

RibFix Blu Thoracic Fixation System Versus Non-surgical

Recruiting
  • Rib; Fracture
  • Non surgical and Surgical
  • Bedford Park, South Australia, Australia
  • +3 more
Feb 3, 2022

Healthy Trial in Nottingham ([14C]-BLU-5937)

Completed
  • Healthy
  • Nottingham, Ruddington, United Kingdom
    Quotient Sciences
Feb 11, 2022

Avapritinib Versus Best Available Therapy in Patients With AdvSM

Completed
  • Advanced Systemic Mastocytosis
  • +3 more
    • Palo Alto, California
    • +5 more
    Dec 17, 2021

    Refractory Chronic Cough Trial in Worldwide (BLU-5937, Placebo)

    Completed
    • Refractory Chronic Cough
    • Peoria, Arizona
    • +115 more
    Dec 10, 2021

    Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor

    Active, not recruiting
    • Advanced Systemic Mastocytosis
    • +3 more
    • Stanford, California
    • +31 more
    Mar 25, 2022

    Chronic Pruritus, Atopic Dermatitis Trial in Canada, United States (BLU-5937, Placebo)

    Completed
    • Chronic Pruritus
    • Atopic Dermatitis
    • Phoenix, Arizona
    • +32 more
    Nov 30, 2021

    Hepatocellular Carcinoma (HCC) Trial in Worldwide (Fisogatinib (BLU-554))

    Active, not recruiting
    • Hepatocellular Carcinoma (HCC)
    • Fisogatinib (BLU-554)
    • Rialto, California
    • +40 more
    Aug 12, 2022